A Growing Treatment—With an Important Safety Concern
If you're a parent of a teen struggling with obesity, you've probably heard about semaglutide (brand name Ozempic or Wegovy). It's becoming increasingly popular in Singapore and across Asia as a weight management tool for adolescents. The drug works by helping reduce appetite and can lead to significant weight loss. But a new case report published in Frontiers in Pediatrics is raising an important red flag that every parent should understand.
What Happened in This Case?
A 16-year-old girl in the study was prescribed semaglutide after nine months on a similar medication. Her doctors gradually increased her dose to the maximum level of 2.4 mg per week. She lost a substantial amount of weight—which sounds positive on the surface. But five weeks after reaching the highest dose, she experienced severe abdominal pain, nausea, and vomiting. Tests revealed she had developed acute pancreatitis (inflammation of the pancreas) triggered by gallstones.
Here's the critical detail: an ultrasound before the dose increase had already shown she had gallstones, though they weren't causing problems at that time. After the semaglutide dose was increased, her condition deteriorated rapidly. She eventually needed surgery to remove her gallbladder.
Why Does This Matter for Singapore Families?
In Singapore and across Asia, childhood obesity is rising, and more doctors are turning to weight loss medications like semaglutide to help teens manage their weight. While the drug can be effective, this case reminds us that even medications used by millions can have serious, though uncommon, complications in certain individuals.
The research team suggests that rapid weight loss combined with dose escalation may stress the gallbladder, potentially triggering problems in teens who already have gallstones. The relationship isn't completely proven, but the timing is suspicious enough that doctors need to be cautious.
For Asian families specifically, this matters because gallbladder disease is not uncommon in our region, and many people may have silent gallstones (gallstones without symptoms) without knowing it.
What Should Parents Do?
The good news: this complication is rare. The warning is not to avoid semaglutide entirely, but to ensure your teen receives proper monitoring if prescribed this medication. Medical supervision is essential before starting, during, and after treatment.
Three Steps for Parents to Take
- Request a baseline ultrasound: Before your teen begins semaglutide or similar weight loss medications, ask your doctor for an abdominal ultrasound to check for pre-existing gallstones. This simple imaging test can identify hidden risk factors.
- Watch the warning signs: During treatment, especially when doses are being increased, educate yourself and your teen about symptoms of pancreatitis: severe upper abdominal pain, persistent nausea, vomiting, and yellowing of the skin. Report these immediately to your doctor—don't wait.
- Prioritize regular check-ups: Ensure your teen has scheduled follow-up appointments with their doctor rather than just taking the medication independently. Dose increases should be gradual and carefully monitored, not rushed. Ask your doctor about the timeline and whether slower escalation might be safer for your teen.